# From mechanosensing to immune regulation: mechanisms of acupuncture signal initiation and amplification mediated by macrophages

**Authors:** Wenru Sheng, Rui Wang, Xiqing Xue, Pan Zhao, Jingwen Zhang, Yiider Tseng

PMC · DOI: 10.3389/fimmu.2026.1744045 · Frontiers in Immunology · 2026-02-16

## TL;DR

This paper explains how acupuncture works by showing how mechanical stimulation at acupoints activates macrophages, which then regulate immune responses and tissue repair.

## Contribution

The paper provides a systematic perspective on how macrophages mediate acupuncture's effects through mechanosensing and immune regulation.

## Key findings

- Macrophages at acupoints sense mechanical signals via Piezo1, TRPV4, integrins, and podosomes.
- Activated macrophages regulate inflammation resolution and tissue repair through M1/M2 polarization.
- Macrophages also regulate T cell responses and collaborate with fibroblasts to repair the extracellular matrix.

## Abstract

The core mechanism of acupuncture therapy lies in converting local mechanical stimulation into systemic physiological regulatory effects. Building on this concept, this review highlights the central role of macrophages in this mechanotransduction event, mainly occurring in the acupoint(s). During acupuncture, the practitioner’s manipulation techniques, such as lifting-thrusting and twisting, cause significant mechanical stress at an acupoint through the entanglement and traction of collagen fibers through the acupuncture needle. This physical signal is transmitted through the extracellular matrix (ECM) and delivered to the mechanosensitive cells, such as fibroblasts and macrophages. Concurrently, while fibroblasts receive the mechanical stimuli, they also release alarmin proteins, such as interleukin-33 (IL-33), to further regulate macrophages’ activities. As a key mechanical sensing and effect unit, macrophages perceive mechanical signals through multiple pathways, including Piezo1, transient receptor potential vanilloid 4 (TRPV4) mechanically sensitive channels, the integrin family of mechanotransduction receptors, and podosomes on the cell body. These pathways promptly initiate intracellular Ca2 fluctuations and promote the Yes−associated protein (YAP) and transcriptional co−activator with PDZ−binding motif (TAZ) for their nuclear translocation, as well as induce other mechanisms, generating a cascade reaction to activate macrophages. After activation, macrophages effectively recruit neutrophils and monocytes by coordinating the chemokine network and dominate the resolution of inflammation and the initiation of tissue repair via dynamic polarization between M1 and M2 phenotypes. Additionally, they regulate T cell-mediated adaptive immune responses through antigen presentation and other means, and collaborate with fibroblasts to promote the remodeling and repair of the ECM. This article focuses on providing a systematic perspective on the cellular and molecular basis of acupuncture initiation through the response of macrophages to acupuncture signals and their regulation of the immune network.

## Linked entities

- **Proteins:** PIEZO1 (piezo type mechanosensitive ion channel component 1 (Er blood group)), scb (scab)

## Full-text entities

- **Genes:** Ptk2 (PTK2 protein tyrosine kinase 2) [NCBI Gene 14083] {aka FADK 1, FAK, FRNK, Fadk, p125FAK}, Trpm7 (transient receptor potential cation channel, subfamily M, member 7) [NCBI Gene 58800] {aka 2310022G15Rik, 4833414K03Rik, 5033407O22Rik, CHAK, CHAK1, LTrpC-7}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Retnla (resistin like alpha) [NCBI Gene 57262] {aka 1810019L16Rik, Fizz-1, Fizz1, HIMF, RELM-alpha, RELMa}, Fn1 (fibronectin 1) [NCBI Gene 14268] {aka E330027I09, Fn, Fn-1}, Trpv2 (transient receptor potential cation channel, subfamily V, member 2) [NCBI Gene 22368] {aka GRC, OTRPC2, VRL-1, Vrl1}, Tafazzin (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 66826] {aka 5031411C02Rik, 9130012G04Rik, G4.5, Taz}, Cd80 (CD80 antigen) [NCBI Gene 12519] {aka B71, Cd28l, Ly-53, Ly53, MIC17, TSA1}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Sun1 (Sad1 and UNC84 domain containing 1) [NCBI Gene 77053] {aka 4632417G13Rik, 5730434D03Rik, Unc84a, mKIAA0810}, Cdk1 (cyclin dependent kinase 1) [NCBI Gene 12534] {aka Cdc2, Cdc2a, p34<CDC2>}, IL33 (interleukin 33) [NCBI Gene 90865] {aka C9orf26, DVS27, IL1F11, NF-HEV, NFEHEV}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, TRPV4 (transient receptor potential cation channel subfamily V member 4) [NCBI Gene 59341] {aka BCYM3, CMT2C, HMSN2C, OTRPC4, SMAL, SPSMA}, Src (src proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 20779] {aka pp60c-src}, Sun2 (Sad1 and UNC84 domain containing 2) [NCBI Gene 223697] {aka B230369L08Rik, C030011B15, Unc84b}, Zyx (zyxin) [NCBI Gene 22793] {aka 9530098H06Rik}, Trav6-3 (T cell receptor alpha variable 6-3) [NCBI Gene 328483] {aka Gm13948, Gm193, Gm4, TCR}, Trpv4 (transient receptor potential cation channel, subfamily V, member 4) [NCBI Gene 63873] {aka 0610033B08Rik, OTRPC4, Trp12, VR-OAC, VRL-2, VROAC}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Csf3 (colony stimulating factor 3 (granulocyte)) [NCBI Gene 12985] {aka Csfg, G-CSF, MGI-IG}, Cd86 (CD86 antigen) [NCBI Gene 12524] {aka B7, B7-2, B7.2, B70, CLS1, Cd28l2}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, PIEZO1 (piezo type mechanosensitive ion channel component 1 (Er blood group)) [NCBI Gene 9780] {aka DHS, ER, FAM38A, LMPH3, LMPHM6, Mib}, Il13 (interleukin 13) [NCBI Gene 16163] {aka Il-13}, Pxn (paxillin) [NCBI Gene 19303] {aka Pax}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Eln (elastin) [NCBI Gene 13717] {aka E030024M20Rik}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, Il1rl1 (interleukin 1 receptor-like 1) [NCBI Gene 17082] {aka DER4, Fit-1, Ly84, ST2L, St2, St2-rs1}, Wnt5a (wingless-type MMTV integration site family, member 5A) [NCBI Gene 22418] {aka 8030457G12Rik, Wnt-5a}, Cd28 (CD28 antigen) [NCBI Gene 12487], Il7 (interleukin 7) [NCBI Gene 16196] {aka A630026I06Rik, Il-7, hlb368}, Bcar1 (breast cancer anti-estrogen resistance 1) [NCBI Gene 12927] {aka Cas, Crkas}, Rhoa (ras homolog family member A) [NCBI Gene 11848] {aka Arha, Arha1, Arha2}, Trpc6 (transient receptor potential cation channel, subfamily C, member 6) [NCBI Gene 22068] {aka LLHWJM002, LLHWJM003, LLHWJM004, TRP-6, Trrp6, mtrp6}, Piezo1 (piezo-type mechanosensitive ion channel component 1) [NCBI Gene 234839] {aka 9630020g22, Fam38a, mKIAA0233}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Lmna (lamin A) [NCBI Gene 16905] {aka Dhe}, Vcl (vinculin) [NCBI Gene 22330] {aka 9430097D22}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Ccl19 (C-C motif chemokine ligand 19) [NCBI Gene 24047] {aka CKb11, ELC, Gm2023, MIP3B, Scya19, exodus-3}, Cxcl1 (C-X-C motif chemokine ligand 1) [NCBI Gene 14825] {aka Fsp, Gro1, KC, Mgsa, N51, Scyb1}, Casp6 (caspase 6) [NCBI Gene 12368] {aka CASP-6, Mch2}, Csf1 (colony stimulating factor 1 (macrophage)) [NCBI Gene 12977] {aka BAP025, Csfm, MCSF, Mhdabap25, PG-M-CSF, op}, Cxcl12 (C-X-C motif chemokine ligand 12) [NCBI Gene 20315] {aka Pbsf, Scyb12, Sdf1, Tlsf, Tpar1}, Il33 (interleukin 33) [NCBI Gene 77125] {aka 9230117N10Rik, Il-33, Il1f11, NF-HEV}
- **Diseases:** pain (MESH:D010146), fibrosis (MESH:D005355), inflammation (MESH:D007249), injury (MESH:D014947), infarcted (MESH:D007238), sepsis (MESH:D018805), necrotic (MESH:D009336), acute myocardial infarction (MESH:D009203)
- **Chemicals:** PGE2 (MESH:D015232), hyaluronic acid (MESH:D006820), NO (MESH:D009569), LPS (MESH:D008070), ATP (MESH:D000255), calcium (MESH:D002118), ROS (MESH:D017382), glycosaminoglycans (MESH:D006025), Ca2 (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), Fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950808/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950808/full.md

## References

108 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950808/full.md

---
Source: https://tomesphere.com/paper/PMC12950808